Azelaic acid — the overlooked active with a wide range of uses.

Azelaic acid is a dicarboxylic acid found naturally in wheat, rye, and barley, and produced in small quantities by the skin's commensal microbiome. In skincare, it is used at concentrations between 10% and 20%. The 20% prescription formulation has the strongest clinical data; the 10–15% over-the-counter range is effective for milder presentations of the conditions it treats.

Its mechanism of action is multi-directional, which is the primary reason it occupies a different position in the routine from most actives. It does not work primarily through exfoliation, barrier modification, or antioxidant activity — it works through anti-inflammatory, antimicrobial, and melanogenesis-inhibiting pathways simultaneously. This breadth is why it appears in protocols for three apparently different concerns: acne, rosacea, and post-inflammatory hyperpigmentation.

What it does

Anti-inflammatory action. Azelaic acid inhibits reactive oxygen species production in neutrophils and keratinocytes, reducing the inflammatory response that drives both inflammatory acne lesions and the erythema associated with rosacea. This mechanism is distinct from niacinamide's cytokine-pathway anti-inflammatory action — the two can be used together with additive benefit.

Antimicrobial activity. Azelaic acid inhibits the growth of Cutibacterium acnes (the bacterium associated with acne), as well as Staphylococcus epidermidis, which plays a role in rosacea exacerbations. Unlike antibiotic treatments, resistance does not develop — a practical consideration for long-term maintenance.

Melanogenesis inhibition. Azelaic acid is a competitive inhibitor of tyrosinase, the enzyme responsible for producing melanin. This makes it effective for post-inflammatory hyperpigmentation — the dark marks left after acne lesions resolve — and for melasma, where it is used as a first-line or adjunct treatment. Its tyrosinase-inhibition mechanism is different from alpha-arbutin or kojic acid, and it inhibits the production of abnormal melanocytes more selectively than uniform pigment reduction.

Comedolytic action. Azelaic acid normalises the aberrant keratinisation within the follicle that contributes to comedone formation. This mechanism overlaps with retinoids — both address the keratinocyte differentiation problem — but through different pathways, which is why they can be used in combination or as alternatives for those who cannot tolerate retinoids.

Who it suits

Azelaic acid has an unusually broad tolerability profile. It is one of the few actives recommended for use during pregnancy (at appropriate concentration, with medical advice). It is suitable for sensitive skin, reactive skin, and rosacea-prone skin that cannot tolerate retinoids or higher-strength acids. Fitzpatrick III–VI skin types dealing with post-inflammatory hyperpigmentation often tolerate azelaic acid better than exfoliating acids that can cause irritation and, paradoxically, worsen hyperpigmentation.

Rosacea. The 15–20% formulation is clinically proven for papulopustular rosacea and is a first-line prescription treatment in multiple dermatological guidelines. At lower over-the-counter concentrations, the anti-inflammatory and antimicrobial action is still present — useful for maintenance, redness reduction, and preventing flares in mild presentations.

Acne. Particularly useful for non-inflammatory comedonal acne and mild-to-moderate inflammatory acne, especially in combination with a retinoid. For those who cannot tolerate retinoids, it provides a gentler alternative with overlapping comedolytic action. Its anti-inflammatory and antimicrobial properties address the bacterial and inflammatory component directly.

Post-inflammatory hyperpigmentation. One of the most effective over-the-counter ingredients for fading acne marks, particularly in medium-to-deeper skin tones where exfoliating acids require caution. Results on a timeline of 8–12 weeks with consistent daily use.

How to use it

Azelaic acid can be applied morning, evening, or both — it is not photosensitising (though SPF remains essential when treating pigmentation, to prevent new hyperpigmentation from UV exposure).

It is stable across a wide pH range and compatible with most other actives. It can be layered with niacinamide for additive anti-inflammatory effect, used alongside a gentle retinoid for combined comedolytic benefit, or applied over a hydrating serum to minimise any transient stinging that some users notice on introduction.

Initial application once daily is sensible; twice daily can be added as tolerance confirms. Transient tingling or mild stinging is common and normal on first application — it typically reduces over one to two weeks. This is distinct from the stinging of incompatible actives and does not indicate irritation.

Realistic expectations

Azelaic acid is not fast. Pigmentation results require consistent daily use over 8–12 weeks. Acne and rosacea improvements are also measured in weeks rather than days. This does not make it less effective — it makes it a maintenance active rather than a quick-fix.

Its value is in the breadth of conditions it addresses simultaneously, the tolerability that allows long-term use, and the absence of the sensitising or barrier-disrupting effects that require cycling in other actives. It is one of few ingredients that can be used without restriction through the seasons, through different skin states, and across a wide age range. An active this well-tolerated and this multi-functional earns its place in a routine without qualification.